Learn / NAMS
NASDAQ: NAMS
NewAmsterdam Pharma Co N.V. (NAMS) stock, explained like you're 5
NewAmsterdam Pharma Co N.V. trades on the Nasdaq under the ticker NAMS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.6 billion dollars.
- Ticker
- NAMS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 2.6 billion dollars
Is NewAmsterdam Pharma Co N.V. a small, medium or large cap company?
No. NewAmsterdam Pharma Co N.V. is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How NewAmsterdam Pharma Co N.V. makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NAMS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- NewAmsterdam Pharma Co NV (KH6.HM) stock price, news, quote and history (Yahoo Finance UK)
- NewAmsterdam Pharma (NasdaqGM:NAMS) Stock Forecast & Analyst Predictions (Simply Wall Street)
- NAMS Nov 2026 30.000 put (NAMS261120P00030000) stock price, news, quote and history (Yahoo Finance UK)
- NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates (Yahoo Finance)
- NAMS Nov 2026 30.000 put (NAMS261120P00030000) interactive stock chart (Yahoo Finance UK)
Follow NAMS in your daily brief
Each trading day at 5 PM ET we post what happened to NewAmsterdam Pharma Co N.V. and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NAMS
Questions about NewAmsterdam Pharma Co N.V. stock
What does NewAmsterdam Pharma Co N.V. do?
NewAmsterdam Pharma Co N.V. trades on the Nasdaq under the ticker NAMS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.6 billion dollars.
What is the ticker symbol for NewAmsterdam Pharma Co N.V.?
NewAmsterdam Pharma Co N.V. trades under the ticker NAMS on the Nasdaq.
What is NewAmsterdam Pharma Co N.V.'s market cap?
NewAmsterdam Pharma Co N.V. is a mid cap stock with a market cap of about 2.6 billion dollars.
How does NewAmsterdam Pharma Co N.V. make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NAMS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NAMS stock every day?
Add NAMS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.